In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing
Rapid Communications in Mass Spectrometry · 30.01.2027 · 41 (2)
DOI: 10.1002/rcm.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 13.11.2026. Verfasst von Michael Benedict Subhahar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE. Hauptthemen laut MEDLINE: Camelus, Doping in Sports. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Rationale
Suzetrigine (VX‐548, Journavx), the first oral non‐opioid selective NaV1.8 sodium channel blocker approved by the US FDA in January 2025 for acute pain management, was investigated for its in vivo metabolic fate and elimination profile in dromedary camels following oral administration.
Methods
Urine and plasma samples were collected over a defined postadministration period and analysed by liquid chromatography coupled to high‐resolution mass spectrometry (LC‐HRMS). The relative abundance of each metabolite was tracked across the sampling window to establish elimination kinetics.
Results
Three metabolites were identified and characterised: two phase I metabolites, M1 ( O ‐demethylation of the methoxyphenyl group) and M2 (monohydroxylation of M1), were detected in urine, while only M1 was observed in plasma. A phase II sulfonate conjugate, M3, was identified exclusively in urine. Compared with the wider metabolite panel from the authors' previously published camel liver study, the in vivo profile was more restricted, reflecting the differences between in vitro biotransformation systems and living biological systems.
Conclusion
These findings provide the first in vivo metabolic reference data for suzetrigine in camels and establish M1 as the primary candidate marker for routine antidoping screening in this species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE.
ORCID-Profile: Michael Benedict Subhahar, Fatma Ibrahim Alhammadi, Shino Ann Koshy, Meleparappil Muhammed Ajeebsanu, Moses Philip, Tajudheen K Karatt, Samir Meissir, Zubair Perwad, Fatma Mohammed Graiban, Abdul Khader Karakka Kal
Zitieren
APA
Subhahar, M. B., Alhammadi, F. I., Koshy, S. A., Ajeebsanu, M. M., Philip, M., Karatt, T. K., Meissir, S., Perwad, Z., Graiban, F. M., & Kal, A. K. K. (2027). In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing. Rapid Communications in Mass Spectrometry, 41(2). https://doi.org/10.1002/rcm.70207
Vancouver
Subhahar MB, Alhammadi FI, Koshy SA, Ajeebsanu MM, Philip M, Karatt TK, et al. In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing. Rapid Communications in Mass Spectrometry. 2027;41(2). doi:10.1002/rcm.70207
BibTeX
@article{Subhahar2027,
author = {Subhahar, Michael Benedict and Alhammadi, Fatma Ibrahim and Koshy, Shino Ann and Ajeebsanu, Meleparappil Muhammed and Philip, Moses and Karatt, Tajudheen K and Meissir, Samir and Perwad, Zubair and Graiban, Fatma Mohammed and Kal, Abdul Khader Karakka},
title = {In Vivo Metabolic Profiling and Elimination Kinetics of Suzetrigine in Dromedary Camels: Implications for Doping Control in Camel Racing},
journal = {Rapid Communications in Mass Spectrometry},
year = {2027},
volume = {41},
number = {2},
doi = {10.1002/rcm.70207}
}
EUVIMED